| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/28/2001 | CN1289250A Methods of decreasing or preventing pain using spicamycin or derivatives thereof |
| 03/28/2001 | CN1289249A Derivatives of 1,3,4-oxadiazolone |
| 03/28/2001 | CN1288896A Quercetin derivative and its medicinal use |
| 03/28/2001 | CN1288885A Alkylating method of hindered sulfonic acid |
| 03/28/2001 | CN1288745A Preparation of externally applied Chinese medicine |
| 03/28/2001 | CN1063749C Azabicyclic esters of carbamino acids used in therapy |
| 03/28/2001 | CN1063638C Scorpion-venom injecta and preparation method thereof |
| 03/28/2001 | CN1063635C Medicine for treating epilepsy |
| 03/27/2001 | US6207803 Amino acid sequence of polypeptide; anticarcinogenic agents; antitumor agents; treatment of automimmune disorders, blood disorders; alzheimer's/parkinson's disease, septic shock, osteoporosis, polycystic kidney disease; viricides; diagnosis |
| 03/27/2001 | US6207801 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same |
| 03/27/2001 | US6207709 N-substituted-2-amino-4-phenyl-4-oxo-butanoic acid compounds having kynurenine-3-hydroxy base inhibitory activity |
| 03/27/2001 | US6207708 For therapy and prophylaxis of autoimmune and/or inflammatory conditions affecting the joints such as arthritis, and inflammatory bowel disease, cardivascular ischemia, diabetes, congestive heart failure, myocarditis, atherosclerosis, |
| 03/27/2001 | US6207680 Heteroarylpiperidines and their use as antipsychotics and analgesics |
| 03/27/2001 | US6207678 Used for treating inflammatory disease such as arthritis, psoriasis, asthma or inflammatory bowel disease, central nervous system disorder such as anxiety, depression, dementia or psychosis, gastrointestinal disorders |
| 03/27/2001 | US6207677 Adminisering sigma receptor binding piperidine derivative for treating anxiety, epilepsy, convulsion, movement disorder, amnesia |
| 03/27/2001 | US6207674 Dextromethorphan and oxidase inhibitor for weaning patients from narcotics and anti-depressants |
| 03/27/2001 | US6207663 Vitronectin receptor antagonists, their preparation and use |
| 03/27/2001 | US6207662 Useful in the treatment of central nervous system disorders, psychotic disorders such as schizophrenia |
| 03/27/2001 | US6207656 Treating neurodegenerative diseases or disorders by administering low calcemic vitamin d analog compound |
| 03/27/2001 | US6207453 A replication-defective adeno-associated virus vector containing exogenous dna bound to a dna which codes for a rep protein; gene therapy |
| 03/27/2001 | US6207147 Cancer immunotherapy using tumor cells combined with mixed lymphocytes |
| 03/27/2001 | CA2201098C Orphan receptor |
| 03/27/2001 | CA2091562C Indole derivatives useful in psychotherapeutics |
| 03/27/2001 | CA2081450C Biologically active peptides containing d-2-alkyltrypthophan |
| 03/23/2001 | CA2309372A1 Use of antibodies against the nef protein for decreasing the chemotaxis which is induced by retrovirus-infected astrocytes |
| 03/22/2001 | WO2001020336A2 SCREENING FOR α2δ-1 SUBUNIT BINDING LIGANDS |
| 03/22/2001 | WO2001020004A2 Protein phosphatase and kinase proteins |
| 03/22/2001 | WO2001019983A1 Human g-protein coupled receptor |
| 03/22/2001 | WO2001019977A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| 03/22/2001 | WO2001019973A2 Nicotinic acetylcholine receptor: alpha10 subunit |
| 03/22/2001 | WO2001019960A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 03/22/2001 | WO2001019870A2 Secreted soluble alpha2delta-2, alpha2delta-3, alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 03/22/2001 | WO2001019867A1 Prion-related protein |
| 03/22/2001 | WO2001019860A2 Proteins associated with cell differentiation |
| 03/22/2001 | WO2001019856A2 Secreted human proteins, polynucleotides encoding them and methods of using the same |
| 03/22/2001 | WO2001019855A2 Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 03/22/2001 | WO2001019851A2 Opaminergic neuronal survival-promoting factors and uses thereof |
| 03/22/2001 | WO2001019850A2 Nrage nucleic acids and polypeptides and uses thereof |
| 03/22/2001 | WO2001019839A1 Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1h-indol-5-ols |
| 03/22/2001 | WO2001019833A1 Thienoisoxazolyl- and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as d4 antagonists |
| 03/22/2001 | WO2001019832A2 Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists |
| 03/22/2001 | WO2001019831A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 03/22/2001 | WO2001019830A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 03/22/2001 | WO2001019829A2 Pyrazolopyrimidines as therapeutic agents |
| 03/22/2001 | WO2001019826A2 Triazolopyrimidine derivatives |
| 03/22/2001 | WO2001019825A1 Pteridinones as kinase inhibitors |
| 03/22/2001 | WO2001019823A2 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 03/22/2001 | WO2001019821A1 Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d4 antagonists |
| 03/22/2001 | WO2001019819A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | WO2001019817A2 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission |
| 03/22/2001 | WO2001019816A1 Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 03/22/2001 | WO2001019814A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | WO2001019808A1 Chemical compounds and compositions and their use as cathepsin s inhibitors |
| 03/22/2001 | WO2001019797A2 HYDROXYALKANOYL AMINOLACTAMS AND RELATED STRUCTURES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| 03/22/2001 | WO2001019796A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 03/22/2001 | WO2001019793A1 4-amino-1-aryl-1,5-dihydro-pyrrole-2-one with anti-convulsive and anxiolytic properties and a method for producing the same |
| 03/22/2001 | WO2001019790A1 Prostaglandin derivatives |
| 03/22/2001 | WO2001019770A2 Rxr modulators with improved pharmacologic profile |
| 03/22/2001 | WO2001019398A1 Method for treatment of symptoms of central nervous system disorders |
| 03/22/2001 | WO2001019397A1 Methods and compositions utilizing rad51 |
| 03/22/2001 | WO2001019371A1 TREATMENT OF MOVEMENT DISORDERS BY ADMINISTRATION OF 5-HYDROXYTRYPTAMINE RECEPTOR/α2 ADRENERGIC RECEPTOR ANTAGONIST COMPOSITIONS |
| 03/22/2001 | WO2001019361A2 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate |
| 03/22/2001 | WO2001019337A2 Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing |
| 03/22/2001 | WO2001019321A2 Methods for treating neuropathic pain using hetreoarylmethanesulfonamides |
| 03/22/2001 | WO2001019320A2 Phospholipid prodrugs of anti-proliferative drugs |
| 03/22/2001 | WO2001019182A1 Nuclear transfer with selected donor cells |
| 03/22/2001 | WO2001008661A3 Opioid sustained-released formulation |
| 03/22/2001 | WO2000073323A3 Adam polynucleotides and polypeptides |
| 03/22/2001 | WO2000067696A3 Lactic acid bacteria with anxiolytic properties and uses thereof |
| 03/22/2001 | WO2000059899A8 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them |
| 03/22/2001 | WO2000055318A3 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 03/22/2001 | WO2000055155A3 Heterocyclic compounds as adenosine deaminase inhibitors |
| 03/22/2001 | WO2000040612A9 Insulin-like growth factor (igf) i mutant variants |
| 03/22/2001 | WO2000040576A3 Thiopyran compounds as inhibitors of mmp |
| 03/22/2001 | WO2000001376A3 Pharmaceutical compositions and their uses for treatment of demyelinating disorders |
| 03/22/2001 | WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors |
| 03/22/2001 | WO1999051240A8 Acylbenzoxazines for enhancing synaptic response(s) |
| 03/22/2001 | DE19944332A1 Antikonvulsiv und anxiolytisch wirkende 4-Amino-1-aryl-1,5-dihydro-pyrrol-2-one und Verfahren zu deren Herstellung Anticonvulsant and anxiolytic 4-amino-1-aryl-1,5-dihydro-pyrrol-2-one and processes for their preparation |
| 03/22/2001 | DE10036855A1 Neue kristalline Form von 6-Hydroxy-3-(4-[2-(piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophenhydrochlorid New crystalline form of 6-hydroxy-3- (4- [2- (piperidin-1-yl) ethoxy] phenoxy) -2- (4-methoxyphenyl) benzo [b] thiophene hydrochloride |
| 03/22/2001 | CA2393896A1 Pteridinones as kinase inhibitors |
| 03/22/2001 | CA2385747A1 Pyrazolopyrimidines as therapeutic agents |
| 03/22/2001 | CA2385308A1 Secreted soluble alpha2delta-2, alpha2delta-3, or alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 03/22/2001 | CA2385234A1 Nrage nucleic acids and polypeptides and uses thereof |
| 03/22/2001 | CA2384974A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 03/22/2001 | CA2384783A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | CA2384782A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | CA2384749A1 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 03/22/2001 | CA2384733A1 Methods and compositions utilizing rad51 |
| 03/22/2001 | CA2384324A1 Proteins associated with cell differentiation |
| 03/22/2001 | CA2384294A1 Nicotinic acetylcholine receptor: alpha10 subunit |
| 03/22/2001 | CA2384081A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 03/22/2001 | CA2383927A1 Protein phosphatase and kinase proteins |
| 03/22/2001 | CA2383565A1 Rxr modulators with improved pharmacologic profile |
| 03/22/2001 | CA2383360A1 Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 03/22/2001 | CA2383177A1 Human g-protein coupled receptor |
| 03/22/2001 | CA2382683A1 Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-¬4-(2-amin-1-yl-ethoxy)-benzyl|-1h-indol-5-ols |
| 03/22/2001 | CA2382633A1 Phospholipid prodrugs of anti-proliferative drugs |
| 03/22/2001 | CA2381252A1 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission |
| 03/22/2001 | CA2377221A1 Hydroxyalkanoyl aminolactams and related structures as inhibitors of a.beta. protein production |
| 03/21/2001 | EP1085014A1 1,5-benzodiazepine derivatives |